(0.08%) 5 521.50 points
(0.14%) 39 898 points
(0.16%) 19 783 points
(-0.07%) $81.57
(0.68%) $2.83
(-0.26%) $2 338.20
(0.10%) $29.56
(0.48%) $1 006.60
(0.06%) $0.932
(-0.02%) $10.53
(0.00%) $0.788
(-0.85%) $87.25
1.69% $ 39.66
@ $39.68
Wydano: 24 birž. 2024 @ 22:40
Zwrot: -0.04%
Poprzedni sygnał: birž. 24 - 20:36
Poprzedni sygnał:
Zwrot: -0.29 %
Live Chart Being Loaded With Signals
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases...
Stats | |
---|---|
Dzisiejszy wolumen | 1.10M |
Średni wolumen | 1.36M |
Kapitalizacja rynkowa | 3.79B |
EPS | $-0.790 ( Q1 | 2024-05-09 ) |
Następna data zysków | ( $0 ) 2024-08-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-13.40 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $1.610 (4.07%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-20 | Levin Arthur A | Sell | 5 000 | Stock Option (Right to Buy) |
2024-06-20 | Levin Arthur A | Buy | 5 000 | Common Stock |
2024-06-20 | Levin Arthur A | Sell | 5 000 | Common Stock |
2024-06-17 | Mccarthy Teresa | Buy | 25 000 | Common Stock |
2024-06-17 | Mccarthy Teresa | Buy | 25 000 | Common Stock |
INSIDER POWER |
---|
0.94 |
Last 99 transactions |
Buy: 2 687 476 | Sell: 2 439 164 |
Wolumen Korelacja
Avidity Biosciences Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
SHLD | 0.978 |
CRAI | 0.972 |
ARYD | 0.97 |
NTRA | 0.97 |
PVAL | 0.969 |
CEG | 0.969 |
GOGL | 0.964 |
WING | 0.963 |
PNTG | 0.962 |
DAVE | 0.962 |
10 Najbardziej negatywne korelacje | |
---|---|
LPSN | -0.965 |
QNRX | -0.964 |
TTEC | -0.963 |
SVC | -0.962 |
AKAN | -0.961 |
AGRX | -0.96 |
UONEK | -0.96 |
AUUD | -0.96 |
FIVN | -0.96 |
CNXC | -0.958 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Avidity Biosciences Inc Korelacja - Waluta/Towar
Avidity Biosciences Inc Finanse
Annual | 2023 |
Przychody: | $9.56M |
Zysk brutto: | $7.46M (78.02 %) |
EPS: | $-2.91 |
FY | 2023 |
Przychody: | $9.56M |
Zysk brutto: | $7.46M (78.02 %) |
EPS: | $-2.91 |
FY | 2022 |
Przychody: | $9.22M |
Zysk brutto: | $7.84M (84.96 %) |
EPS: | $-3.24 |
FY | 2021 |
Przychody: | $9.33M |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-2.73 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Avidity Biosciences Inc
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease; AOC 1044 for the treatment of Duchenne Muscular Dystrophy; and AOC 1020 designed to treat facioscapulohumeral muscular dystrophy which are in preclinical stage. It also offers Lumizyme therapy for Pompe diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej